Frequently Asked Questions

CebuTRT serves patients across the Philippines, including in Manila, Cebu, Makati, Taguig, Davao, Quezon City, Parañaque, Pasig, Mandaue, Angeles City, and Dumaguete. Our high-quality care is fully virtual, with medications delivered directly to your door.

TRT is typically recommended for men who have clinically low testosterone levels and symptoms associated with low testosterone, such as decreased libido, fatigue, muscle weakness, and mood changes. Our providers will evaluate your medical history, symptoms, and blood tests to determine if TRT is appropriate.

Testosterone is a hormone naturally produced by your body, which typically adapts well to its presence. Although TRT is often well-tolerated, finding the optimal dose for your unique physiology may require some time. While most side effects of TRT are usually due to excessive dosing, even normal doses can lead to certain effects such as a potential worsening of sleep apnea and a decrease in sperm count.

The timeline for experiencing the benefits of TRT can vary. Some men report feeling more energetic and sexually active within a few days, while others may take a few weeks or months to notice significant changes.

TRT can contribute to muscle growth and fat loss, especially when combined with diet and exercise. However, it’s not a standalone solution for weight loss or bodybuilding. Its primary goal is to restore normal hormone levels, which can indirectly aid in improving body composition.

The duration of TRT depends on the individual’s response and the underlying cause of low testosterone. Some men may need lifelong treatment, while others might use it for a shorter period. Regular monitoring and consultation with a healthcare provider are essential to determine the appropriate length of treatment.

CebuTRT is partnered with endocrinologists responsible for pioneering hormone replacement therapy in the Philippines. Since its founding in 2008, their Manila clinic has provided expert guidance to hundreds of high-profile celebrities, business leaders, and politicians. CebuTRT aims to extend this elite level of care to expats around the country, ensuring that those who seek the best in healthcare can access world-class treatment while in the Philippines.

We recommend Hi-Precision Diagnostics for the following tests. (Chat with them on Facebook to arrange in-home service.)

• Total Testosterone
• CBC
• Metabolic panel
• PSA (for patients over the age of 40)

Our partner pharmacy prioritizes safety and efficacy by sourcing therapeutics directly from leading manufacturers in the United States and Europe. Our commitment to quality ensures that you receive the most reliable testosterone products available. Our team comprises the country’s most experienced hormone experts, dedicated to providing you with the best possible care.

PSA testing before and two months after starting Testosterone Replacement Therapy (TRT) is crucial for monitoring prostate health. Initial testing establishes a baseline PSA level, helping to ensure safe commencement of TRT, especially important for detecting underlying prostate conditions. Subsequent testing after 2 months assesses how TRT affects the prostate, crucial for early detection of potential issues such as prostate cancer or exacerbation of pre-existing conditions. While TRT does not cause prostate cancer, it may actually help identify existing prostate issues with proper testing.

TRT does not change prostate size. On the contrary, testosterone was shown as an important modulator of lower urinary tract function, and TRT probably exerts a positive effect on LUTS/BPH. In addition, multiple studies have shown that Testosterone Replacement Therapy (TRT) does not significantly increase the risk of developing or exacerbating prostate cancer. The Prostate Saturation Model suggests that prostate cancer growth is only dependent on testosterone up to a certain point, known as the saturation point. Beyond this, additional testosterone does not increase cancer risk. Systematic reviews and large-scale studies, including over 70,000 patients, have reinforced this understanding, finding no significant differences in cancer recurrence or mortality between testosterone users and non-users. These findings suggest that TRT, particularly after treatment for localized prostate cancer, is generally safe and does not elevate the risk of prostate cancer progression.